Talk:Secukinumab
Latest comment: 9 years ago by GingerBreadHarlot in topic Mechanism of Action
| This is the talk page for discussing improvements to the Secukinumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Secukinumab.
|
FDA Approved edit
I noticed the legal status of this drug has changed. It appears the pharmaceutical drug Secukinumab with the product name Cosentyx http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm430969.htm was just recently approved by the FDA. GingerBreadHarlot (talk) 17:19, 11 February 2015 (UTC)
Mechanism of Action edit
Does the drug block interleukin 17 or the receptor? GingerBreadHarlot (talk) 17:20, 11 February 2015 (UTC)